Antiva Biosciences, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Antiva Biosciences, Inc. is a clinical-stage biotechnology company focused on developing topical therapies to treat diseases caused by human papillomavirus (HPV) infection. Its goal is to prevent cancer by addressing high-grade HPV-related pre-cancerous lesions, including AIN2/3 in the anal region and CIN2/3 in the cervix. The company advances a proprietary pro-drug chemistry platform intended to enhance the safety and efficacy of antiviral agents. Founded in 2012 as Hera Therapeutics at the University of California San Diego by Dr. Karl Hostetler, Antiva is based in South San Francisco, California. Its lead programs are in clinical trials, reflecting its position in the biotechnology sector as a developer of topical therapies for HPV-associated precancerous conditions. In 2021, Antiva expanded its governance by adding Jenny Yip to the board of directors.